SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RAPEZZI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.441
AS - Asia 11.089
EU - Europa 8.250
SA - Sud America 2.236
Continente sconosciuto - Info sul continente non disponibili 792
AF - Africa 316
OC - Oceania 26
Totale 37.150
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.917
SG - Singapore 4.622
IT - Italia 2.365
FI - Finlandia 2.341
CN - Cina 1.795
BR - Brasile 1.714
VN - Vietnam 1.346
PL - Polonia 1.192
HK - Hong Kong 1.156
BD - Bangladesh 679
DE - Germania 499
FR - Francia 395
GB - Regno Unito 372
ID - Indonesia 364
RU - Federazione Russa 325
JP - Giappone 298
MX - Messico 224
IN - India 205
CA - Canada 194
AR - Argentina 184
UA - Ucraina 157
NL - Olanda 154
TR - Turchia 124
ZA - Sudafrica 123
SE - Svezia 121
IQ - Iraq 90
EC - Ecuador 84
CO - Colombia 75
AT - Austria 64
PK - Pakistan 58
MY - Malesia 49
VE - Venezuela 45
SA - Arabia Saudita 44
ES - Italia 42
MA - Marocco 41
CL - Cile 38
EG - Egitto 34
CH - Svizzera 32
PY - Paraguay 32
UZ - Uzbekistan 32
PH - Filippine 28
TN - Tunisia 28
AE - Emirati Arabi Uniti 23
AU - Australia 22
BO - Bolivia 22
KE - Kenya 22
JO - Giordania 21
NP - Nepal 21
PE - Perù 21
BE - Belgio 19
IE - Irlanda 19
LT - Lituania 19
CR - Costa Rica 18
UY - Uruguay 17
HN - Honduras 16
JM - Giamaica 16
CZ - Repubblica Ceca 15
KZ - Kazakistan 14
PT - Portogallo 14
GR - Grecia 12
MD - Moldavia 12
NI - Nicaragua 12
AZ - Azerbaigian 11
BG - Bulgaria 11
SN - Senegal 11
DZ - Algeria 10
IL - Israele 10
IR - Iran 10
LY - Libia 10
RO - Romania 10
BY - Bielorussia 9
GT - Guatemala 9
KR - Corea 9
SV - El Salvador 9
TW - Taiwan 9
AL - Albania 8
ET - Etiopia 8
LB - Libano 8
OM - Oman 8
RS - Serbia 8
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
HR - Croazia 6
HU - Ungheria 6
NG - Nigeria 6
PS - Palestinian Territory 6
TH - Thailandia 6
AO - Angola 5
CI - Costa d'Avorio 5
GE - Georgia 5
KW - Kuwait 5
SY - Repubblica araba siriana 5
BH - Bahrain 4
CY - Cipro 4
EE - Estonia 4
MM - Myanmar 4
NZ - Nuova Zelanda 4
PA - Panama 4
PR - Porto Rico 4
SI - Slovenia 4
Totale 36.306
Salva come PNG Salva come JPEG
Città #
Singapore 2.621
Helsinki 2.245
Ashburn 1.853
San Jose 1.181
Warsaw 1.177
Hong Kong 1.142
Fairfield 1.011
Santa Clara 984
Beijing 717
Woodbridge 540
Houston 469
Wilmington 419
Ho Chi Minh City 411
Seattle 381
Cambridge 340
Chandler 336
Council Bluffs 323
New York 320
Princeton 309
Jakarta 290
Lauterbourg 282
Hanoi 268
Tokyo 267
Los Angeles 240
Milan 210
Dallas 208
Rome 196
Ann Arbor 190
Mexico City 149
São Paulo 149
Moscow 144
Chicago 140
San Diego 140
Munich 137
London 116
Jacksonville 113
Dong Ket 93
Shanghai 93
Naples 87
Bologna 85
Nuremberg 80
Buffalo 70
Toronto 70
Ferrara 63
Rio de Janeiro 63
Turku 56
Frankfurt am Main 54
Haiphong 53
Orem 52
Falls Church 51
Da Nang 50
Phoenix 50
Tianjin 50
Atlanta 49
Denver 49
Florence 48
Boardman 47
Montreal 44
Palermo 44
Baghdad 43
Brooklyn 43
Johannesburg 43
Stockholm 43
Belo Horizonte 40
Chennai 37
Turin 35
Nanjing 34
Bari 33
Izmir 32
Quito 31
Redwood City 31
Tashkent 31
Bremen 30
Dhaka 30
Brasília 29
Guangzhou 29
Salt Lake City 29
Poplar 28
San Francisco 28
Manchester 27
Biên Hòa 26
Hải Dương 26
Norwalk 26
Campinas 24
Guayaquil 24
Boston 23
Lahore 23
Washington 23
Kuala Lumpur 22
Medellín 22
Vienna 22
Amman 21
Miami 21
Mountain View 21
Porto Alegre 21
Tampa 21
Bogotá 20
Buenos Aires 20
Curitiba 20
San Anselmo 20
Totale 22.571
Salva come PNG Salva come JPEG
Nome #
Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications 2.018
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel 942
Documento di consenso ANMCO/SIC sulla gestione delle miocarditi 856
Linee guida ESC 2015 per il trattamento dell'endocardite infettiva: Task Force per il Trattamento dell'Endocardite Infettiva della Società Europea di Cardiologia (ESC): Con il patrocinio dell'Associazione Europea di Chirurgia Cardiotoracica (EACTS) e dell'Associazione Europea di Medicina Nucleare (EANM) 486
POPDC1S201F causes muscular dystrophy and arrhythmia by affecting protein trafficking 429
Long-term safety of drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis 246
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 238
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 227
Heart failure with preserved ejection fraction: uncertainties and dilemmas 224
Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study 219
Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis 216
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 215
Defining the Diagnosis in Echocardiographically Suspected Senile Systemic Amyloidosis 201
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure 200
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction 197
Nonbiopsy diagnosis of cardiac transthyretin amyloidosis 194
Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis 193
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 193
Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role 192
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 192
Functional characterization of two novel mutations in scn5a associated with brugada syndrome identified in Italian patients 189
Gender-related risk of myocardial involvement in systemic amyloidosis 187
Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study 187
Cardiac Calcifications: Phenotypes, Mechanisms, Clinical and Prognostic Implications 182
A targeted proteomics approach to amyloidosis typing 181
La diagnosi elettrocardiografica di infarto miocardico acuto nell'era dell'angioplastica primaria e delle reti hub and spoke 181
ARNIs: balancing “the good and the bad” of neuroendocrine response to HF 179
Treatment of cardiac transthyretin amyloidosis: An update 177
COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? 177
Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients 175
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies? 174
Cardiopulmonary exercise testing predicts prognosis in amyloid cardiomyopathy: a systematic review and meta-analysis 172
Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy 172
Left ventricular myocardial noncompaction with advanced atrioventricular conduction disorder and ventricular arrhythmias in a young patient: Role of MIB1 gene 169
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies 168
Well-known and novel players in endothelial dysfunction: Updates on a notch(ed) landscape 167
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response 166
Long-term Follow up of Patients with Acute Aortic Syndromes: Relevance of both Aortic and Non-aortic Events 166
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis 164
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 164
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey) 163
Diastolic dysfunction, frailty and prognosis in elderly patients with acute coronary syndromes 162
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice 160
'Corona' versus 'coronary' 160
Neurological involvement in Ile68Leu (p.Ile88Leu) ATTR amyloidosis: not only a cardiogenic mutation 160
The Mediterranean diet: a cultural journey 159
Predictors of atrial fibrillation in hypertrophic cardiomyopathy 157
Atrial Fibrillation in β-Thalassemia: Overview of Mechanism, Significance and Clinical Management 155
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types 153
Cardiac amyloidosis: the great pretender 153
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study 153
Standard ecg in brugada syndrome as a marker of prognosis: From risk stratification to pathophysiological insights 152
Looking for a tailored therapy for heart failure: Are we capable of treating the patient instead of the disease? 152
Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome - Results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) study 151
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 150
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients with Coronary Stent: How Important Is the Interplay between Stent Type and Time from Stenting to Surgery? 149
Current evidence on the diagnostic and prognostic role of native T1 mapping in heart diseases 148
The battle against COVID-19: Mortality in Italy 148
2019 CORONAVIRUS: What are the implications for cardiology? 147
Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index 146
99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis 146
The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification 146
The Residual Risk of Cerebral Embolism after Carotid Stenting: The Complex Interplay between Stent Coverage and Aortic Arch Atherosclerosis 145
Dronedarone: Una reale innovazione o solo una valida seconda scelta? Come districarsi tra linee guida, agenzie regolatorie e pratica clinica quotidiana 145
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology 144
The combination of chest computed tomography and standard electrocardiogram provides prognostic information and pathophysiological insights in COVID-19 pneumonia 144
A Pathogenic Galactosidase A Mutation Coexisting With an MYBPC3 Mutation in a Female Patient With Hypertrophic Cardiomyopathy 143
Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA) 142
Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review 139
State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis 139
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: A systematic review and meta-analysis 139
Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics 138
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 137
Phenotypic heterogeneity of COVID-19 pneumonia: clinical and pathophysiological relevance of the vascular phenotypea 137
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy 136
Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial) 135
Broadening the Phenotypic Spectrum and the Diagnostic Needs of TTR-Related Cardiac Amyloidosis 135
Assessment of patients with hereditary transthyretin amyloidosis–understanding the impact of management and disease progression 135
Risk Scores for Cardiac Implantable Electronic Device Infection: Which One to Believe In? 134
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD) 133
European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology 133
Myocarditis in COVID-19 patients: current problems 133
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 133
One year on: The impact of COVID-19 on clinical research 133
Zero-fluoroscopy cardiac ablation: Technology is moving forward in complex procedures—A novel workflow for atrial fibrillation 132
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 131
Adapting to survive 130
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis 129
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 129
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths 128
Impact of high-sensitivity Troponin T on hospital admission, resources utilization, and outcomes 128
Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man 127
Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis 126
Atrial Flutter in Patient With Critical COVID-19: Beneficial Effects of Rhythm Control on Respiratory Distress 126
Performance of Synthetic Extracellular Volume Fraction in Different Cardiac Phenotypes From a Prospective Cohort of Patients Referred for Cardiac Magnetic Resonance 126
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 125
Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy 123
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 123
Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome 121
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization 121
Totale 19.802
Salva come PNG Salva come JPEG
Categoria #
all - tutte 231.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.483
Totale 233.313
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.975 133 87 52 33 73 136 188 188 106 197 209 573
2022/20231.696 323 42 120 92 152 186 124 137 179 86 159 96
2023/20241.368 79 130 74 64 114 122 74 85 49 60 68 449
2024/20256.241 220 88 616 193 650 503 204 184 988 1.227 769 599
2025/202619.946 1.180 712 1.556 2.280 2.083 941 1.648 1.137 3.478 1.976 2.193 762
2026/2027569 569 0 0 0 0 0 0 0 0 0 0 0
Totale 37.150